Newsletter Subject

NYU Leadership Gaslights Residents Over Hazard Pay

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sun, Apr 26, 2020 11:06 AM

Email Preheader Text

Weekly Review Sunday, April 26, 2020 CME SPOTLIGHT ADVERTISEMENT CME SPOTLIGHT CME SPOTLIGHT CME SPO

[MEDPAGE TODAY]( Weekly Review Sunday, April 26, 2020 [NYU Leadership Gaslights Residents Over Hazard Pay]( [Steam Clean Checks Out for N95 Sterilization]( [Near 90% Mortality Rate in Intubated COVID-19 Patients in NYC]( CME SPOTLIGHT [Real-World Strategies to Support Oncology Teams Who Care for Women with Recurrent Ovarian Cancer]( [Fear of the False Negative COVID-19 Test]( [COVID-19 Anosmia MRI; Vision and Dementia; PPE Headache]( ADVERTISEMENT [Med Students Face Unsure Future During Pandemic]( CME SPOTLIGHT [Improving Patient Outcomes in Follicular Lymphoma Through Quality Care Initiatives]( [COVID-19: Not Your Typical ARDS?]( [CMS Sets Path for Resuming Elective Surgeries as COVID-19 Eases]( [NYC Healthcare Workers Get Coronavirus Antibody Tests]( CME SPOTLIGHT [Approaches for Early Diagnosis, Risk Stratification, and Multidisciplinary Management of Stage I/II Melanoma]( [HCQ Tied to Increased Mortality in Male Vets With Severe COVID-19]( [Dialysis Services at Breaking Point with COVID-19]( [Tx for Worsening Dyspnea Appeared to Help, But Led to Tragic Results]( CME SPOTLIGHT [ALK- or ROS1-Rearranged NSCLC: Effectively Integrating Precision Medicine into Patient-Centered Care]( [Seizures and COVID-19]( [Why These Athletes Went Ahead With Their Elective Surgeries]( [Remdesivir Fails in Severe COVID-19 Trial in China]( CME SPOTLIGHT [Teaming Up to Improve Hemophilia Control: Learning Sessions for Patients, Caregivers, and Health Care Providers]( [International Docs Held Back From COVID Front Lines]( [HHS to Dole Out Billions More for COVID-19 Providers]( [Farxiga Tested as COVID-19 Tx; Intensify Metabolic Control for Prevention]( CME SPOTLIGHT [New and Emerging Treatment Options for Refractory HER2+ Metastatic Breast Cancer]( [Dialysis Industry Ramping Up to Support Hospitals Slammed by COVID-19]( [High-Dose CQ Tied to Death, Cardiac Events in COVID-19 Patients]( [Study: TV Time Directly Causes Heart Events]( CME SPOTLIGHT [Applying Precision Medicine for Patient-Centered, Quality Care for Acute Myeloid Leukemia]( [Personal ECG Devices Filling in on COVID-19 Drug Monitoring]( [Screen Time for Babies Tied to Autism Symptoms Later]( [Want to Fix the Healthcare System? Leave It to the Professionals -- Us]( [Relaxed FDA Requirements for Psych Apps; Social Distancing Suicide Spike?]( [Medical Waste in a Pandemic; Making Primary Care Appealing]( [An Unsafe Interaction Between Pradaxa and Common Meds]( [High Demand for Travel Nurses]( [Concerns Over Telehealth Fraud; Fear of Dying Alone]( Weekly Survey [COVID-19: Patient Panels Survey]( Tell us about your experience treating patients in this era of COVID-19 What concerns you most? [[○] Logistics to mitigate patient exposure risk (in-person versus telehealth)]( [[○] Effective exam & diagnosing]( [[○] Personal risk/exposure]( [[○] Exam reimbursement]( [[○] Prescription cost]( [[○] Treatment compliance]( [Continue]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? Medpage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2020 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2020-04-26&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

06/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.